KLK3 and cancer: Aćimović et al. developed an application of a parallel LSPR biodevice with enhanced analytical performances (high-throughput, fast, and real-time monitoring) for the analysis of two well-known cancer markers: human alpha-feto-protein (AFP) and PSA.